Advocacy groups filed a lawsuit on behalf of 3 Medicaid recipients challenging Arkansas' Medicaid work requirements; CVS Health announced that its pharmacy benefit manager will target expensive drugs to be excluded from formularies if they are not cost effective; Senate leaders have received a letter from 120 consumer and patient associations on the impact Supreme Court nominee Brett Kavanaugh could have on health policy.
The Trump administration is facing another lawsuit over its decision to allow states to impose work requirements in Medicaid. Similar to an earlier lawsuit over Kentucky’s work requirements, advocacy groups filed a lawsuit on behalf of 3 Medicaid recipients in Arkansas, reported Reuters. The lawsuit claims the administration does not have the capability to approve work requirements under the federal Medicaid law. In June, a federal judge blocked Kentucky’s work requirements.
In a recent white paper, CVS Health announced that its pharmacy benefit manager will target expensive drugs to be excluded from formularies if they are not cost effective. According to The Center for Biosimilars®, a sister site of The American Journal of Managed Care®, CVS Caremark will rely on data from the Institute for Clinical and Economic Review to determine cost effectiveness. CVS has already implemented efforts to curb costs, and the white paper identifies 3 additional strategies it will begin to employ.
Senate leaders have received a letter from 120 consumer and patient associations on the impact Supreme Court nominee Brett Kavanaugh could have on health policy. InsideHealth Policy reported that the Supreme Court might be hearing cases on the constitutionality of the Affordable Care Act, access to women’s healthcare services, state accountability for violating Medicaid requirements, and attempts to roll back Medicaid coverage. Kavanaugh could be a deciding vote on all of these health issues.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More